ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products.

RVL Pharmaceuticals is launching a prescription e-commerce platform.

ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional savings for practices, the Company states.

RVL Pharmaceuticals is a specialty pharmaceutical company focused on the commercialization of UPNEEQ (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults.

For more information about ELEVATE, visit lowlyinglids.com.